About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Brain Connectivity

Founding and Co-Editors-in-Chief: Christopher P. Pawela, PhD
and Bharat B. Biswal, PhD

ISSN: 2158-0014 • 10 Issues Annually • Online ISSN: 2158-0022

Current Volume: 4

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    Scope and Aims
    Brain Connectivity is an international neuroscience journal dedicated to the publication of original reports and scientific reviews concerned with all aspects of anatomical, functional, and causal connections between distinct units within the central nervous system. Articles describing the underlying mechanisms and structure behind brain connections will be given priority. Emphasis will be placed on the following experimental techniques: magnetic resonance imaging (MRI), electroencephalography (EEG), magnetoencephalography (MEG), positron emission tomography (PET), single photon emission computed tomography (SPECT), microscopy, and other new and evolving methods as applied to brain connectivity analysis. Submission of multimodal examinations and integrations is encouraged. The journal will consider studies in both human and animal models. Brain Connectivity is an investigational journal, and research reports are strongly recommended to contain experimental data. Three article categories will be included: original manuscripts, communications, and review articles. Several sub-categories under original articles and communications will be considered, including reports of original experimental data, methodological studies, novel data analysis schemes, theoretical data modeling, and descriptions of changes in brain connectivity in health and disease. Reports of original investigations in the areas of neuroscience, neurology, physics, biophysics, computer science, neuroinformatics, mathematics, chemistry, biochemistry, physiology, developmental biology, genetics, molecular biology, psychiatry, pharmacology, anesthesiology, cell biology, and brain anatomy relevant to the field of brain connectivity will be accepted.

    Preparation of Manuscripts
    Manuscripts must be uploaded to Manuscript Central  (http://mc.manuscriptcentral.com/brainconnectivity) in a word processing format, preferably in Microsoft Word. Please follow these instructions carefully.


    Use of English Language
    All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in Brain Connectivity.  For authors whose native language is not English, we suggest using a service that can aid in the translation and rewriting of material into correct and proper English usage.

    Title Page
    The title (first) page of all manuscripts must contain the following information:

    • Exact of 150-180 characters or fewer (including spaces)
    • Names of ALL authors, their institutional affiliations including full postal address; city, state, country name, and email addresses
    • Name, address, telephone and fax numbers, and e-mail address of the corresponding author
    • Running head of 60 characters or fewer (including spaces)
    • Provide 6–8 keywords


    An unstructured abstract should accompany every original manuscript, communication, and review article. The abstract should appear on a separate page after the title page. The abstract should be no more than 250 words and should conform to the following guidelines:

    • Do not use proprietary or trade names in the title or abstract
    • The use of the first person should be avoided
    • Clearly summarize the results and conclusions of the work
    • References are not permitted in the abstract



    The Journal publishes all accepted papers within 72 hours of acceptance in their unedited, uncorrected format.  It is important to note that the information that is published online, and in all indexing services, is pulled directly from the data that is populated into the fields in Manuscript Central – NOT from the manuscript file – when the paper is originally uploaded to the system for peer review.  Consequently, any errors contained in the system will remain on our website and all indexing services, including Medline, until the next revision of the article is published.  As such, it is critical that authors enter all authors’ names correctly into the system at the time of submission.

    The next revision will take place after the corresponding author sees page proofs, makes any necessary corrections, and returns the changes to the Publisher.  Once the alterations are completed, the revised version will be published on our website, and the newly corrected information will then be released to Medline/PubMed, in addition to any other indexing services in which the Journal is included.

    Please note that the typical time between acceptance of a paper and page proof distribution is approximately 4-8 weeks depending on the length and complexity of the paper.

    Text Instructions

    Indicate order of overall article:

    • Title Page
    • Abstract
    • Acronyms page
    • Body (Include main headings:  Introduction; Materials and Methods; Results; Discussion; Conclusion)
    • Acknowledgments
    • Disclosure Statement
    • References
    • Figure Captions


    • Original Manuscripts:                        4,500–5,000 words
                                                                       Maximum of 10 figures
                                                                       Approximately 50 references

    • Communications:                               3,500 Words
                                                                       Maximum of 6 figures
                                                                       Approximately 30 references

    • Reviews:                                               7,000–7,500 words
                                                                       No limit on figures
                                                                       Approximately 80-100 references

    • Commentaries/Controversies:       Submit abstract via email to the Editor at
                                                                       jofbrainconnectivity@gmail.com prior to
                                                                       submission to determine if the topic is the 
                                                                       appropriate subject matter for Brain Connectivity.


    • Write the body of the manuscript as clearly and concisely as possible.  
    • To facilitate the review process, the use of sub-sections within main headings is strongly suggested.  All original submissions should include the following main headings: Introduction; Materials and Methods; Results; Discussion; Conclusion
    • Adhere to the manuscript category word limits described herein
    • Abstracts, headings, legends, disclosures, and references do not contribute to word count 
    • Number and double space all pages
    • Use Times New Roman or Arial fonts in 12-point type
    • References should be prepared in the name/date format.  Any references cited in text must be included in the reference list, and conversely, all references in the reference section must be cited in text.

    The reference section must be double-spaced, and should be arranged in alphabetical order.  More than one reference from the same author(s) in the same year must be identified by the letters "a", "b", "c", etc., placed after the year of publication (i.e.: 2010a), and should be listed chronologically, beginning with the most recent year. Within text, the citation should be included in parentheses followed by the year of publication. (Ex:  Jones et al, 2009.) The author is responsible for the accuracy and completeness of the references.

    In all citations, use et al. for any references containing more than six authors.)

    Journals:  (Abbreviate journal names in accordance with MEDLINE.)

    Mueller SG, Schuff N, Yaffe K, Madison C, Miller B, Weiner MW. 2010. Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease.  Hum Brain Mapp 31:1339-1347.

    Conference Abstracts:

    Tropp J. RF Field Penetration as a Function of Quality Factor in Simple Dielectric Resonators. In Proceedings of the 10th Annual Meeting of ISMRM, Honolulu, Hawaii, USA, 2002, p. 912.


    Woolsey TA,  Gado MH, Roberts MP. 1998. The Brain Atlas. Valley Stream, NY:  Fitzgerald Science Press. p. 265

    (Include volume and/or edition numbers when appropriate.)

    Chapter in Book

    Koester J, Siegelbaum SA. 2000. The nervous system expresses a rich variety of voltage-gated ion channels. In: Kandel ER, Schwartz JH, Jessell TM (eds.) Principles of Neuroscience, 4th ed. New York, NY: McGraw Hill; p. 159.

    (Include volume and/or edition numbers when appropriate.)

    Websites:  (Do not include http:// in a website address if www. is present in the URL; include it only if www. is omitted.)

    McDonald T.  Hopes common drug will help dementia patients.  www.abc.net.au/news/stories  Last accessed Nov. 2, 2010.

    Unpublished Material:

    When a reference is unpublished data, a manuscript in preparation, or a manuscript submitted but not in press, it should be included in parentheses in the body of the text, and not cited in the reference list. Personal communications should also be listed parenthetically in text, and should contain the first initial and last name of the contact, as well as the month and year of the communication. Published manuscripts, and those that have been accepted and are pending publication, should be cited in the reference list.

    Preparation of Figures and Legends

    Figure Legend Instructions:

    • Include a separate page in the manuscript containing all table and figure legends
    • Prepare legends double-spaced
    • Define all relevant information in figures, including figure part labels, footnotes, abbreviations, acronyms, arrows, and levels of magnification in insets
    • Each figure should have a corresponding figure legend, and should be brief and pertinent

    The depiction of data presented in Brain Connectivity is of the utmost importance to our audience.
    Please be sure to follow these specific guidelines for submitting figures:

    • Do NOT embed art files into a Word or PDF document. Figures provided in this format cannot be used for production purposes
    • Line illustrations should be submitted at 900 dpi
    • Halftones and color should be submitted at a minimum of 300 dpi
    • To ensure proper print quality, please submit only TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process
    • Color art must be saved as CYMK—not RGB. (Note: If RGB files are submitted, the files will be converted to CYMK and some color variation will occur. This conversion could result in misinterpretation of data)
    • PowerPoint and Excel figures cannot be uploaded
    • Use 12-point Times New Roman or Arial fonts for any labeling within figures

    You will be given directions on how to correct any files which do not pass.
    Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
    • All files should be scanned at 100% size.
    • 300 dpi
    • Final color mode: cmyk
    • save file as: .tif or .eps
    If you need directions on how to convert a Power Point slide to acceptable format go to www.liebertpub.com/MEDIA/pdf/ppconvert.pdf

    Preparation of Tables
    Table Instructions
    Prepare all tables on separate pages in Word. Cite tables in the order in which they appear in the text using Arabic numerals. Provide a table title for all tables.

    Chemical  Formulae  and  Mathematical  Equations 
    Wherever possible, write mathematical equations  and  chemical  formulae on  a  single  line.  Please submit complex chemical  structures  as figures. Number equations sequentially in Arabic numerals at the right margin.

    Please include a list of all abbreviations used in the article. All acronyms and their definitions should be spelled out in a separate list on a separate page immediately after the title page. Acronyms should be defined the first time they are listed in the text. Brain Connectivity discourages the use of unnecessary acronyms. Overuse of acronyms can cause reduced clarity and therefore the use of acronyms should be limited whenever possible.  


    Please upload individual files of all manuscript material—do NOT upload a single PDF file containing all text, figure, and table files of your manuscript. Once all individual files are uploaded to Manuscript Central, the system will automatically create a single PDF proof for the peer-review process.

    After the Conclusion(s) portion of the manuscript, include a separate section acknowledging any contributors who did not meet the requirements for authorship and any science writers or corporate employees who participated in the development of the manuscript. Also include acknowledgments of research support for the study.

    Disclosure Statement
    Immediately following the Acknowledgments section, include a section entitled ‘‘Author Disclosure Statement.’’ This text must be included before the references. In this portion of the manuscript, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the manuscript is being reviewed and will not influence the editorial decision.

    If no conflicts exist, the authors must state ‘‘No competing financial interests exist.’’

    Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at www.icmje.org/index.html#conflicts for further guidance.

    NOTE: The disclosure portion of the manuscript is NOT included in the word limit.

    Ethical Considerations in the Conduct and Reporting of Research:
    Protection of Human Subjects and Animals in Research

    When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

    *This portion of Brain Connectivity’s Instructions for Authors has been quoted directly from the Uniform Requirements for Manuscripts Submitted to Biomedical Journals website. For more information, visit www.icmje.org/ethical_6protection.html

    Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title. Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc. By submitting a manuscript to the Journal, the author(s) agree(s) to each of the above conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.

    Upon acceptance of any manuscript, all authors will receive a follow-up email with instructions on how to complete our online Copyright Agreement form.  It is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications.


    The corresponding author is responsible for communicating with coauthors to make sure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.

    Authors are responsible for procuring permissions to reproduce Illustrations or tables taken from other publications, and must be acknowledged by a complete credit line in the legend. [Publisher should provide an example of a credit line here.] The original publisher’s letter of permission should be available for submission to Brain Connectivity if requested by the Editor or the Publisher. A full citation should also be included in the reference list.

    Page Proofs
    An email containing a link to the PDF file of the page proof is sent to the corresponding author. The proof should be read very carefully and returned within 3 days to the Publisher with the author’s approval and/or corrections.

    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

    Brain Connectivity is published 10 times a year by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215, Tel: (914) 740-2100; Fax: (914) 740-2101; Email: info@liebertpub.com; Website: www.liebertpub.com.

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Journal of Neurotrauma

    Journal of Neurotrauma

    Provides advances in clinical and laboratory investigations of TBI and SCI, focuses on pathobiology of injury to the central nervous system, and presents preclinical and clinical trials from onset through long-term care.

    Therapeutic Hypothermia
    and Temperature Management

    Therapeutic Hypothermia
    and Temperature Management

    Provides a strong multidisciplinary forum to ensure research advances are well disseminated and therapeutic hypothermia is used effectively to enhance patient outcomes from traumatic brain injury, cardiac arrest, and more.

Browse All Publications »